Sigyn Therapeutics
(OTC) SIGY
Sigyn Therapeutics Financials at a Glance
Market Cap
$64.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$5.77K
Net Income (TTM)
-$3.22M
EPS (TTM)
-$2.01
P/E Ratio
-0.02
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.04
Volume
95,529
Open
$0.04
Price
$0.04
Volume
95,529
Open
$0.04
Previous Close
$0.04
Daily Range
$0.04 - $0.04
52-Week Range
$0.01 - $5.00
Estimated Earnings Date
May 19, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.04
Volume
95,529
Open
$0.04
Previous Close
$0.04
Daily Range
$0.04 - $0.04
52-Week Range
$0.01 - $5.00
Estimated Earnings Date
May 19, 2026
SIGY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sigyn Therapeutics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
4
CEO
James A. Joyce
Website
www.sigyntherapeutics.comHeadquarters
San Diego, CA 92106, US
SIGY Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
49.66%
Return on Capital
N/A
Return on Assets
-1990.29%
Earnings Yield
-50.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$64.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
1.61M
Volume
95.53K
Avg. Volume
45.61K
Financials (TTM)
Gross Profit
$1.52K
Operating Income
-$1.88M
EBITDA
-$2.00M
Operating Cash Flow
-$936.43K
Capital Expenditure
-$4.00
Free Cash Flow
-$936.43K
Cash & ST Invst.
$85.57K
Total Debt
$2.81M
Sigyn Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$64.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$16.05K
N/A
Employees
4
N/A
Net Income
-$578.50K
+51.7%
EBITDA
-$576.48K
+30.7%
Quarterly Fundamentals
Total Cash
$85.57K
-48.1%
Total Debt
$2.81M
+45.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
-100.0%
Long Term Debt
$2.06M
+2660.3%
Short Term Debt
$750.86K
-59.6%
Return on Assets
-19.90%
N/A
Return on Invested Capital
36.38%
N/A
Free Cash Flow
-$199.33K
-21.7%
Operating Cash Flow
-$199.33K
-21.7%